ZFP36
Code No: RN031PW
Datasheet:
FID:7391 | PATH:sites/default/files/datasheets/RN031PW.PDF
Background:
ZFP36 or tristetraprolin (TTP) is a member of the family of zinc finger proteins; ZFP36 was first identified as a gene that was rapidly induced by the stimulation of fibroblasts with growth factors and mitogens. Native human TTP expressed in neutrophils, lymphocytes, and monocytes is primarily cytoplasmic, and this protein is highly phosphorylated in vivo. TTP is an mRNA binding protein; it binds to AU-rich elements in mRNA and removes the poly(A) tail, consequently increasing the rate of mRNA turnover. The most characterized gene regulated by TTP is the AU-rich tumor necrosis factor alpha (TNF-alpha) gene. TTP binds to the AU-rich element (ARE) in the 3′ UTR of TNF mRNA, and regulates the rate of TNF mRNA turnover in vivo. Recent studies showed that polyA-binding protein 1 (PABP1) inhibits the degradation of the TNF poly(A) tail by TTP.
Product Type:
Primary Antibody
Species Reactivities:
Human
Related Products:
RN001P Anti-EIF4E (polyclonal)
RN002P Anti-EIF4G1 (polyclonal)
RN003P Anti-EIF4G2 (polyclonal)
RN004P Anti-ELAVL1/HuR (polyclonal)
RN005P Anti-ELAVL2/HuB (polyclonal)
RN006P Anti-ELAVL3/HuC (polyclonal)
RN007P Anti-IGF2BP1/IMP1 (polyclonal)
RN008P Anti-IGF2BP2/IMP2 (polyclonal)
RN009P Anti-IGF2BP3/IMP3 (polyclonal)
RN010P Anti-MSI1/Musashi1 (polyclonal)
References:
Rowlett, R. M., et al., Am. J. Physiol. Gastrointest. Liver Physiol. 295, G421-G430 (2008)
Carrick, D. M., et al., Arthritis Res. Ther. 6, 248-264 (2004)
Fairhurst, A. M., et al., Arthritis Res. Ther. 5, R214-R225 (2003)
Kontoyiannis, D., et al., Immunity 10, 387-398 (1999)
Intended Use:
For Research use only. Not for use in diagnostic procedure.
|